Mediating role of circulating inflammatory proteins in the effect of immune cells on esophageal cancer risk: A Mendelian randomization study

Jinzhou Guo,Gao Si,Xuejie Song,Fuchun Si
DOI: https://doi.org/10.1097/md.0000000000040374
IF: 1.6
2024-11-06
Medicine
Abstract:Esophageal cancer (EC) is a common malignant tumor of the digestive system. According to GLOBOCAN 2020, EC ranks seventh globally in incidence and sixth in mortality, with the highest rates in East Asia. [ 1 ] EC is known for its aggressive nature and poor prognosis. The overall 5-year survival rate is less than 30%, dropping to 5% for advanced cases. [ 2 ] Survival rates vary significantly depending on the stage of diagnosis and availability of medical resources. EC shows notable geographical variation, with high-incidence regions known as the "esophageal cancer belt." There are 2 primary belts: one in Central and East Asia, and the other in Eastern and Southern Africa. [ 3 ] Asia, especially East Asia, faces the highest risk of EC due to a complex interplay of dietary habits, environmental exposures, and genetic factors. [ 4 , 5 ] The immune system and inflammatory processes also play significant roles in cancer development. [ 6 ] Understanding the relationships between immune cells, circulating inflammatory proteins, and EC is crucial for elucidating the mechanisms of carcinogenesis and developing targeted therapies.
medicine, general & internal
What problem does this paper attempt to address?